SCHEMBL426115

SCHEMBL426115

O=C(c1ccccc1)c1cccc(-c2cc3ccccc3[nH]2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.62
RAB9A P51151 3/20 0.62
ESR1 P03372 1/20 0.60
EGFR P00533 2/20 0.54
PIK3CA P42336 2/20 0.54
CASP3 P42574 2/20 0.54
SENP8 Q96LD8 2/20 0.54
SENP7 Q9BQF6 2/20 0.54
SENP6 Q9GZR1 2/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
POLB P06746 1/20 0.54
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CYP19A1 P11511 1/20 0.48
KDM4E B2RXH2 3/20 0.47
HPGD P15428 3/20 0.47
MAPT P10636 2/20 0.47
ALDH1A1 P00352 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13814181 0.90 CASP3 (0.54) NPC1RAB9AESR1EGFRPIK3CA
SCHEMBL22887391 0.89 CASP3 (0.68) NPC1RAB9AESR1CASP3SENP8
SCHEMBL423127 0.88 FLT3 (0.61) NPC1RAB9AESR1EGFRPIK3CA
SCHEMBL427120 0.87 NPC1 (0.63) NPC1RAB9AESR1CASP3SENP8
SCHEMBL10227452 0.86 CTNNB1 (0.51) NPC1RAB9AESR1EGFRPIK3CA
SCHEMBL430192 0.85 NPC1 (0.57) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL10226049 0.85 CASP3 (0.52) NPC1RAB9AESR1EGFRPIK3CA
SCHEMBL428051 0.84 NPC1 (0.56) NPC1RAB9AESR1CASP3SENP8
SCHEMBL10226047 0.84 GPR84 (0.55) NPC1RAB9AESR1CASP3SENP8
SCHEMBL426111 0.83 SMO (0.55) NPC1RAB9AESR1CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR TUBB, TUBB3, TUBB1 NPC1 3214/4885RAB9A 2378/4885ESR1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.